Review of the revised plan for off-site treatment of Newport Chemical Agent Disposal Facility’s Caustic VX Hydrolysate at the DuPont Secure Environmental Treatment Facility in Deepwater, New Jersey : summary of the report to Congress. Corrected version.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Review of the revised plan for off-site treatment of Newport Chemical Agent Disposal Facility’s Caustic VX Hydrolysate at the DuPont Secure Environmental Treatment Facility in Deepwater, New Jersey : summary of the report to Congress. Corrected version.

Filetype[PDF-2.26 MB]


  • English
    • Details Related Documents You May Also Like

    Details:

    • Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
    • Description:
      cdc:130732

      This report presents the findings of the follow-up review of the U.S. Army proposal for Caustic VX Hydrolysate (CVXH) waste transportation, treatment, and subsequent discharge of treated material into the Delaware River. The U.S. Army’s plan for destroying their stockpile of bulk VX, a nerve agent developed for use in chemical warfare results in a treatment byproduct known as CVXH. The review was a joint effort by the Centers for Disease Control and Prevention (CDC) and the U.S. Environmental Protection Agency (EPA).

      In a March 29, 2004, letter to CDC, the four U.S. Senators from New Jersey and Delaware, along with four members of the House of Representatives asked CDC to formally review the proposal for off-site treatment of CVXH to determine “if there is public health risk involved with the Army’s proposal.” This report, referred to as Phase I, identified several limitations of the available data that required resolution (1). They then asked both the U.S. Army and CDC to work together to address the remaining issues from the Phase I report and to review the proposed DuPont phosphonate removal process. The Army and DuPont conducted several studies and submitted the results to CDC and EPA for review.

      correctedvxreport06.pdf

    • Subjects:
    • Document Type:
      Report
    • Place as Subject:
      New Jersey
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov